Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
ACG Case Rep J ; 9(12): e00937, 2022 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-36600797

RESUMO

Eosinophilic gastrointestinal diseases are rare disorders characterized by infiltration of eosinophils in one or multiple segments of the gastrointestinal tract. Hypersensitivity to food or environmental allergens is believed to play an important role in the pathogenesis. In this case report, we describe a 61-year-old man who developed eosinophilic gastroenteritis and colitis with severe peripheral eosinophilia after intragastric balloon (IGB) placement for weight loss. His symptoms and peripheral eosinophilia improved rapidly after removal of the IGB without the need for immunomodulatory therapies or diet modifications. This case suggests a possible association between IGB and eosinophilic gastrointestinal diseases, which warrants clinicians' awareness and further studies.

2.
Anticancer Res ; 31(12): 4135-9, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22199271

RESUMO

BACKGROUND: Overexpression of excision repair cross complementing group 1 (ERCC1), a DNA repair enzyme, is associated with resistance to cisplatin. MATERIALS AND METHODS: Tissues from 73 patients with squamous cell carcinoma of the head and neck (HNSCC) who received concurrent cisplatin and radiation was analyzed immunohistochemically to determine if ERCC1 expression predicted for survival and response. Expression was scored as follows: 0=0% tumor nuclei positive, 1+=<50%, 2+=50-75% and 3+=>75%. RESULTS: ERCC1 expression was 0 in 0%, 1+ (14%), 2+ (42%) and 3+ (44%). In uni- and multivariate analyses, 3+ ERCC1 expression was not a significant predictor of survival or response. Median survival for the ERCC1 3+ patients was 2.9 years versus 2.1 years for the ERCC1 <3+ group (p=0.44). CONCLUSION: In this retrospective review of HNSCC patients receiving concurrent cisplatin and radiation, ERCC1 expression was not a significant predictor of survival or response.


Assuntos
Cisplatino/uso terapêutico , Terapia Combinada/métodos , Proteínas de Ligação a DNA/biossíntese , Endonucleases/biossíntese , Regulação Neoplásica da Expressão Gênica , Neoplasias de Cabeça e Pescoço/tratamento farmacológico , Neoplasias de Cabeça e Pescoço/radioterapia , Radioterapia/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Antineoplásicos/farmacologia , Reparo do DNA , Neoplasias de Cabeça e Pescoço/metabolismo , Humanos , Imuno-Histoquímica/métodos , Pessoa de Meia-Idade , Estudos Retrospectivos , Resultado do Tratamento
3.
Breast Dis ; 33(1): 45-8, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21965307

RESUMO

We report a rare case of mammary fibroadenoma in a 75 year old male patient with emphasis on imaging findings and review of the previously reported cases.


Assuntos
Neoplasias da Mama Masculina/diagnóstico , Fibroadenoma/diagnóstico , Idoso , Humanos , Masculino , Mamografia , Tomografia Computadorizada por Raios X , Ultrassonografia Mamária
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...